In line with the idea that HPDL is a CoQ10 biosynthesis enzyme, the clinical manifestation of HPDL deficiency ranges from early-onset encephalopathy up to adolescent-onset spastic paraplegia. This evidence concerns the gene HPDL and Spastic paraplegia.